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for persons with hereditary nonpolyposis colorectal carcinoma 
(HNPCC; Muir-Torre syndrome is a special kind of HNPCC or 
Lynch syndrome), and the risk for developing colorectal cancer is 
dramatically enhanced in persons with HNPCC (80–82% vs. 5–
6% in the general population). 
 Nevertheless, an appropriate tool helping in selecting families 
for immunohistochemical and/or molecular genetic analysis to 
identify MMR gene mutations are the Amsterdam criteria II and 
the revised Bethesda guidelines ( table 1 )  [6, 7] . Because bladder 
cancer is not an HNPCC-related cancer, only the younger sister 
of the index patient could comply with the revised Bethesda 
guidelines, and their parents if they are alive. Additionally, in 
families where one member fulfilled at least one of the clinical 
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 We read with interest the article ‘Fibrous papule of the face 
with granular cells’  [1] . The authors analyzed a patient with a re-
current transitional cell carcinoma of the bladder for expression 
of the DNA mismatch repair genes  MLH1  and  MSH2 . Unfortu-
nately, the family history is not given in detail.
 Fibrous papules of the face and neck can be found in families 
with different autosomal dominant tumor syndromes such as 
Birt-Hogg-Dubé syndrome, Cowden disease, Gardner syndrome 
and tuberous sclerosis  [2–4] .
 The family history of the presented patient exhibits many dif-
ferent neoplasias, similar to a multisystemic cancer predisposi-
tion disorder like Cowden disease, also known as multiple ham-
artoma syndrome. Patients with Cowden disease have an in-
creased potential to develop benign and malignant neoplasms in 
a variety of tissues. The mostly benign cutaneous tumors are in-
dicative of internal malignancies and may precede the develop-
ment of the internal manifestations by many years. Benign skin 
tumors are facial papules, trichilemmomas, sclerotic fibromas 
and fibroangiomas, for example, whereas associated malignant 
skin tumors are basal cell carcinoma or sebaceous carcinomas 
amongst others. Furthermore, malignant neoplasias could affect 
the internal organs like the colon, urinary bladder and stom-
ach  [4] .
 It would be helpful to mention the age of onset of patients as 
the probability for the incidence of invasive cancers arises with 
age. Thus, of all male individuals in the USA aged 60–69 years, 
1.67% develop colorectal cancer versus 1.16% of all US females, 
and 0.96% develop urinary bladder cancer versus 0.26% of the fe-
male population  [5] . In the population aged 70 and older there are 
4.92% of the male population developing colorectal cancer versus 
4.45% of females and 3.41% of males develop urinary bladder can-
cer versus 0.96% of females, respectively. Furthermore, colorectal 
cancer is the 3rd most frequent cancer in males and females, and 
bladder cancer is the 4th most frequent in the USA. The lifetime 
risk for bladder cancer in the general population is 1–3% and 4% 
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Table 1. Amsterdam criteria II and revised Bethesda guidelines
Amsterdam criteria II
There should be at least 3 relatives with CRC or with a Lynch-syn-
drome-associated cancer: cancer of the endometrium, small bow-
el, ureter or renal pelvis
– One relative should be a first-degree relative of the other 2
– At least 2 successive generations should be affected
– At least 1 tumor should be diagnosed before the age of 50 
years
– FAP should be excluded in the CRC case if any
– Tumors should be verified by histopathological examination
Revised Bethesda guidelines
1 CRC diagnosed in a patient aged <50 years
2 Presence of synchronous, metachronous colorectal or other 
Lynch-syndrome-related tumors, regardless of age
3 CRC with MSI-H phenotype diagnosed in a patient aged <60 
years
4 Patient with CRC and a first-degree relative with a Lynch-syn-
drome-related tumor, with one of the cancers diagnosed at an 
age <50 years
5 Patient with CRC with 2 or more first-degree or second-degree 
relatives with a Lynch-syndrome-related tumor, regardless of 
age
CRC = Colorectal cancer; FAP = familial adenomatous pol-
yposis; MSI-H = high-frequency microsatellite instability. Lynch-
syndrome-related tumors include colorectal, endometrial, stom-
ach, ovarian, pancreas, ureter, renal pelvis, biliary tract and brain 
tumors, sebaceous gland adenomas and keratoacanthomas, and 
carcinoma of the small bowel.
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selection criteria corresponding to the Amsterdam II criteria or 
the Bethesda guidelines, the sensitivity of the immunohisto-
chemical analysis for  MLH1 and  MSH2 was shown to be 94% in 
tumors  [8] , whereas in sebaceous hyperplasia only 3% show mic-
rosatellite instability  [9] .
 Concerning HNPCC and Muir-Torre syndrome, it would be 
even more efficient in the presented family to investigate the co-
lon cancer of the patient’s sister. 
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 Thank you for your interest in our paper and for your letter. 
We think that the first aim of the article was to focus on a special 
type of fibrous papule: the granular variant which is rare. This is 
expressed in the title of the paper. We wanted to describe the his-
topathological findings and immunohistochemical characteris-
tics of this rare tumor. We also discuss the differential diagnosis. 
Our patient had only 1 fibrous papule and not multiple lesions 
which are typically seen in Cowden’s disease. The typical perifol-
licular fibromas with the mantle-like proliferation of the follicle 
are completely different from the histology of our single lesion of 
a fibrous papule, and this was the reason why we never thought 
about Birt-Hogg-Dubé syndrome. Therefore, we believe that in 
our case the occurrence of granular cells in a fibrous papule was 
an incidental finding in a patient with a family background sug-
gesting a familial cancer syndrome which has not yet been com-
pletely classified. If in the future there are other findings in the 
proband or his family we will publish them. 
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